Recent Articles from Investor Brand Network

President Donald Trump’s executive order issued on December 18 signaled a shift in US medical cannabis policy, opening new paths for research and fueling a wave of mergers and acquisitions across the sector. However, one essential issue remains unresolved: how will patients receive medical marijuana in a way that resembles standard healthcare?

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using cutting-edge technology to reach target markets, has developed and is commercializing its Digital Engagement Engine(TM). The solution combines automation, unique data management and microservices architecture to elevate digital content and drive better digital interactions within current and new communities. “The company anchored the development of the Digital Engagement Engine(TM) in data analysis and smart technology, creating a tech stack that can identify even the narrowest of niches within clients’ respective target markets, tailor content to meet their exact needs, and deliver the content to them right when they need it,” a recent article reads. “Remarkably, XESP’s approach is not lifted from the conventional customer experience (‘CX’) playbook; it is rather unique. And as the company’s CEO Peter Hager explained in an interview with Proactive, this uniqueness is responsible for making the company good at what it does. ‘We just took an immense amount of focus on what happens when you’re not face to face with your customers. Many people look at the customer experience as a face-to-face [interaction] or just the brand, but they haven’t really followed the journey of the customer when they’re not face to face,’ explained Hager. XESP resolved to tackle the underlying problem by creating a system that allows client companies to sense and respond to what their users and customers are looking for when interacting with them digitally. This approach, according to Hager, created an edge.”

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, announced that Chief Executive Officer and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, taking place Feb. 17–19, 2026, in Boston. During a Day Two presentation on Feb. 19, Mr. Sharma will highlight how the Company’s RADR® AI and machine learning platform supported the development of STAR-001, a brain-penetrant therapeutic candidate, including insights into mechanism of action, biomarker identification, indication selection, and novel combination strategies for aggressive CNS cancers such as glioblastoma and ATRT.

Crypto markets are known for their speed, size, and surprises. But even in this fast-moving world, what happened at a South Korean crypto exchange shocked many people. A simple mistake turned into a $40 billion problem almost instantly.

After a staggering rally of nearly 150% last year, the price of silver has hit a particularly rough patch amid elevated market volatility that started last week. On Thursday alone, the price plunged nearly 20%. The rout started during early trading in the Asian markets and continued when U.S. markets opened.

Elon Musk announced that SpaceX has acquired his AI company, xAI, in a deal that brings together two of his most high-profile ventures and tightens the links between his work in space technology and AI development.

Olenox Industries (NASDAQ: OLOX) announced the appointment of Erik Blum and Adam Falkoff to its Board of Directors, effective Feb. 6, 2026. The appointments fill existing board vacancies, with both directors serving until the Company’s 2025 Annual Meeting of Shareholders and participating in the Company’s non-employee director compensation program, as Olenox adds leadership experience spanning public company turnarounds, corporate finance, public policy, and global strategic advisory.

MedWell Ai (OTCQB: MWAI) announced that it has signed a letter of intent to create a vertically integrated health, wellness, and longevity platform organized across three core divisions: national pharma distribution and telemedicine, a nationwide portfolio of surgical, cosmetic, and men’s health centers, and an advanced biologics and product innovation group. The proposed consolidation includes Ageless Cosmetic Surgery Centers, Apollo BioWellness and its biologics subsidiary, and MedWell USA, with the combined company projecting more than $25 million in annual revenue in 2026 based on trailing 2025 revenues of $14 million, assuming successful closings and adequate funding, as parties move forward with due diligence targeting transaction completion within 60 days.

White Pearl Acquisition (NYSE: WPACU) announced that it closed its initial public offering on Feb. 3, 2026, issuing 11,500,000 units at $10.00 per unit, including 1,500,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The units began trading on the New York Stock Exchange on Feb. 2, 2026, under the symbol “WPACU,” with each unit consisting of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share upon completion of an initial business combination, while the Company’s Class A ordinary shares, units, and rights trade under the symbols “WPAC,” “WPACU,” and “WPACR,” respectively, and D. Boral Capital LLC acted as sole bookrunner for the offering.

From lab research to clinical application, photodynamic therapy (“PDT”) is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma (“CTCL”) and other inflammatory skin diseases using targeted photodynamic mechanisms that aim to improve outcomes while minimizing systemic toxicity.

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration Office of Orphan Products Development for Orphan Drug Designation for NV-387 as a treatment for measles. If granted, the designation would make the Company eligible for incentives including tax credits for qualified clinical trials, exemptions from certain FDA user fees, and up to seven years of market exclusivity following approval, supporting the regulatory development of NV-387 amid rising measles cases in the United States and globally.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Perpetuals.com (NASDAQ: PDC), a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, is positioning itself at the intersection of traditional financial infrastructure and blockchain-based systems, targeting institutions that want exposure to digital assets without stepping outside regulated frameworks. The company develops software that allows regulated trading venues to operate continuously, with self-clearing and blockchain-native settlement replacing legacy post-trade processes.

VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients worldwide, including leading pharmaceutical and diagnostic companies using the assays to support disease research, drug development, and late-stage clinical trials.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) announced the launch of Barrier Futures, a proprietary, MiFID II-compliant derivatives product designed as a regulated alternative to offshore perpetual futures and retail contracts for difference, addressing markets that collectively represent multi-hundred-trillion dollars in annual notional volume. The Company said Barrier Futures offer defined-risk positions without margin calls while enabling brokers to participate through a scalable B2B model that includes trading fee revenue shares, spread participation, and white-label licensing, with the platform expected to go live for qualified brokers in March 2026 and initial partnerships targeted for Q1.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

As an abundant element in the universe, hydrogen has an extensive range of applications, among them its use as a carrier of clean energy in fuel cells in cars and in oil refining. With the automotive industry continuously expanding, the demand for alternative fuels like hydrogen has grown exponentially.

China has begun producing sodium-ion electric vehicles, moving ahead of Western automakers like Tesla and opening the door to a new category of EVs. CHANGAN Automobile recently unveiled an electric passenger car powered by a sodium-ion battery supplied by CATL, with volume production expected to begin later this year.

While people have been quick to blame health insurers for the skyrocketing cost of health care in the U.S., the reality of the situation is more nuanced, and other factors have played a much bigger role in driving up costs. We explore some of those less-reported drivers of the high cost of health care in the country.

Military flight training has long followed a familiar formula: structured lessons, carefully staged challenges, and instructors judging progress only by performance. In the Netherlands, researchers are now testing a system that could change that model by allowing simulators to respond directly to what is happening inside a pilot’s brain .

Earth Science Tech (OTC: ETST), a strategic holding company focused on acquiring and scaling high-potential operating businesses, announced that it will report financial results for the three months ended Dec. 31, 2025, after the close of trading on Tuesday, Feb. 17, 2026.

A new analysis shows that roughly 90% of China’s investment growth last year came from green energy, underscoring how decisively clean industries now drive the country’s economic expansion. According to research from the Center for Research on Energy and Clean Air published by Carbon Brief , clean energy sectors propelled more than 90% of capital growth in 2025 and now rival all but seven national economies in scale.

Concerns about China’s stance on digital assets have resurfaced as Bitcoin drifts deeper into bear market conditions. Chinese authorities have announced a tighter interpretation of their existing cryptocurrency ban, moving to explicitly outlaw activities tied to real-world asset (RWA) tokenization and unapproved stablecoins tied to the yuan.

On Friday, China launched an experimental reusable spacecraft in a mission that was shrouded in secrecy like the previous three such launches. Announcements about this mission were reported by Xinhua, a state-run media organization.

Forward Industries (NASDAQ: FWDI) the leading Solana treasury company, announced that it will host a conference call on Thursday, Feb. 12, 2026, at 5 p.m. Eastern Time to discuss its financial and operating results for the three months ended Dec. 31, 2025, with financial results to be released in a press release prior to the call; the Company’s executive team will host the call and webcast presentation, followed by a question-and-answer period.

Ohio Attorney General Dave Yost has approved the official title and summary language for a proposed referendum that seeks to roll back the state’s recent changes to its recreational marijuana laws. The decision clears a major procedural hurdle for advocates who want voters to weigh in on Senate Bill 56, a measure adopted by lawmakers late last year.

XTI Aerospace (NASDAQ: XTIA), an aerospace technology company focused on scaling its Drone Nerds, LLC subsidiary, outlined its operating leverage, expanding customer base, and near-term value creation initiatives during its Shareholder Town Hall held Feb. 5, 2026. Management provided full-year 2026 revenue guidance for the first time, projecting revenue to exceed $160 million, representing approximately 30% growth, and emphasized disciplined execution following the November 2025 acquisition of Drone Nerds, which has positioned the Company as a scaled enterprise drone and unmanned aircraft systems platform serving enterprise, government, and defense-adjacent customers.

Safe Pro Group Inc. (NASDAQ: SPAI), a developer of AI-powered defense and security solutions, is presenting at the 2026 Defence Leaders Combat Engineer & Logistics Conference (“CEL26”) in Krakow, Poland ( https://ibn.fm/u4HK9 ).

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, a company that’s pioneering proton therapy systems for treating tumors in various types of cancers.

Solowin Holdings (NASDAQ: AXG), a financial technology firm bridging traditional and digital assets, announced a partnership with Taobao Shangou, a subsidiary of Alibaba Group, and Hangzhou Bossen to deploy an integrated model combining high-quality carbon assets, consumer platform incentives, and on-chain carbon credit circulation. The collaboration leverages AXG’s Ferion asset tokenization platform to enable compliant, transparent lifecycle management of carbon assets, which are embedded into Taobao Shangou’s consumer incentive system to reward users for low-carbon behaviors such as green delivery and sustainable purchasing choices, supporting China’s national and provincial carbon peaking and carbon neutrality objectives and establishing a scalable framework for inclusive carbon reduction.

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics using proprietary intranasal delivery technology, today outlined targeted milestones for 2026 as it advances ONP-002, a novel intranasal neurosteroid, toward Phase 2 clinical development. The Company is preparing to initiate a Phase 2a clinical trial of ONP-002 in Australia for the treatment of concussion and mild traumatic brain injury (mTBI), positioning the candidate as a potential first-in-class pharmacological therapy for a large and underserved global market following positive preclinical and Phase 1 safety and efficacy results.

Renewal Fuels (OTC: RNWF), also known as American Fusion, announced the appointment of Dr. John E. Brandenburg, Ph.D., as chief technology officer of Kepler Fusion Technologies, effective immediately. Dr. Brandenburg is a senior plasma physicist with more than four decades of experience spanning fusion energy, advanced propulsion, and applied plasma physics, and brings deep technical expertise to the Company’s mission of commercializing its Texatron(TM) aneutronic fusion platform. His career includes senior scientific roles at Lawrence Livermore National Laboratory, Sandia National Laboratories, The Aerospace Corporation, the Florida Space Institute at Kennedy Space Center, and Orbital Technologies Corporation, along with service under multiple U.S. government security clearances supporting sensitive defense and energy research programs.

Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow that the AI boom could be inflating a bubble . While concerns about a potential bust are becoming more common, Meta’s latest earnings suggest that, for now, the market is still willing to back heavy investment, particularly when it produces clear financial results.

The cryptocurrency market is once again under pressure as prices continue to fall, and experts are warning that the pain may not be over yet. Bitcoin and Ethereum, the two largest digital assets, have both recorded sharp losses, raising concerns among traders, investors, and analysts worldwide.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company developing smart, autonomous solutions for manned and unmanned aerial systems, announced its participation in Enforce Tac 2026, Germany’s leading trade fair for security and defence, taking place Feb. 23–25, 2026, at the Exhibition Centre Nuremberg. ParaZero will exhibit its DefendAir counter-UAS systems within the Israeli National Pavilion, organized by the Israel Export Institute, highlighting its multi-layered, non-explosive drone interception technology and supporting the Company’s strategy to expand its European footprint following successful demonstrations to German law enforcement and senior NATO officials in late 2025.

Wisconsin Democratic lawmakers recently introduced legislation that would legalize marijuana for both recreational and medical use, renewing a long-running debate as the state continues to lag behind nearby Midwestern neighbors on cannabis policy. Michigan and Illinois already permit recreational cannabis, while Minnesota has moved in the same direction. Wisconsin, by contrast, still treats most marijuana possession as a crime.

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts in addressing some of the pressing challenges in cancer treatment. “Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target,” reads a recent article. “LIXTE’s platform is built on its proprietary LB-100 compound, a one-of-a-kind inhibitor of Protein Phosphatase 2A (‘PP2A’). PP2A is a critical enzyme involved in various cellular processes, including cell growth regulation, DNA repair, and modulation of the immune response. Through the selective inhibition of PP2A, LB-100 is strategically designed to make cancer cells more treatable while also boosting the body’s immunity to tumors… This strategic approach is important because resistance and limited efficacy are major impediments in oncology. Different cancers fail to respond adequately to immunotherapy. The company’s strategy is not aimed at replacing these therapies, but rather at improving them, making it possible for standard treatments to work for more patients.”

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts in addressing some of the pressing challenges in cancer treatment. “Instead of developing standalone cancer drugs, the company is adopting a different strategy aimed at enhancing the overall effectiveness of existing immunotherapy and chemotherapy regimens through a novel biological target,” reads a recent article. “LIXTE’s platform is built on its proprietary LB-100 compound, a one-of-a-kind inhibitor of Protein Phosphatase 2A (‘PP2A’). PP2A is a critical enzyme involved in various cellular processes, including cell growth regulation, DNA repair, and modulation of the immune response. Through the selective inhibition of PP2A, LB-100 is strategically designed to make cancer cells more treatable while also boosting the body’s immunity to tumors… This strategic approach is important because resistance and limited efficacy are major impediments in oncology. Different cancers fail to respond adequately to immunotherapy. The company’s strategy is not aimed at replacing these therapies, but rather at improving them, making it possible for standard treatments to work for more patients.”

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed the company’s release of positive top-line results from its phase 2 clinical trial evaluating SGX945 for the treatment of aphthous ulcers associated with Behçet’s. “Behçet’s disease is a rare, chronic inflammatory condition that can cause recurrent, painful ulcers, eye inflammation and systemic complications that significantly affect quality of life. Because available treatments are limited and often inconsistent, clinical trial updates in this disease area carry particular importance. Soligenix is reporting results from a phase 2a proof of concept study evaluating its investigational therapy, SGX945 (dusquetide), for the treatment of Behçet’s disease, representing a notable step forward in efforts to improve care for patients with this underserved condition… SGX945 is a novel innate defense regulator designed to modulate the body’s immune response rather than broadly suppress it. Soligenix explains that this mechanism aims to reduce harmful inflammation while preserving the immune system’s ability to fight infection, a critical distinction from many existing immunosuppressive therapies. In the phase 2 study, SGX945 was reported to be safe and well tolerated, an important consideration for a chronic disease requiring repeated or long-term treatment.”

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

As investor interest in advanced technology platforms grows alongside breakthroughs in research, materials science and data-driven innovation, Xeriant (OTCQB: XERI) is shaping a strategy that extends well beyond any single product or material solution. Rather than positioning itself as a one-technology company, Xeriant is increasingly defining its identity around building an integrated innovation ecosystem focused on accelerating discovery, development and commercialization of high-impact technologies, including nanotech.

Labor volatility has become one of the most persistent structural challenges facing the hospitality industry. Even as demand has returned across hotels, venues, and resorts, staffing shortages, call offs, and physical strain on frontline workers continue to pressure margins and service consistency. Rather than replacing workers outright, operators are increasingly exploring automation models that function as workforce support, reducing friction in day-to-day operations while preserving the human element that defines hospitality.

SKYX Platforms (NASDAQ: SKYX) announced the launch of its newly patented all-in-one ceiling plug & play SKYFAN & Turbo Heater at Home Depot, including the debut of a dedicated SkyPlug branding page for the product and other plug & play offerings on HomeDepot.com. The Home Depot launch is expected to support increased visibility, consumer education, and demand throughout fiscal year 2026 as the company expands penetration across professional and retail channels. The SKYFAN & Turbo Heater combines a ceiling fan with an integrated turbo heater to provide year-round heating and cooling while improving safety, efficiency, and space utilization compared with traditional portable heaters. SKYX also said it plans to expand variations, finishes, and additional SKUs in response to early demand and retailer engagement, with production underway through its manufacturing partners.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) was featured in a NetworkNewsAudio Audio Press Release examining how automation is reshaping service speed and revenue capture in high-traffic hospitality environments such as stadiums, conventions and live events. The editorial highlights how demand surges during narrow service windows can directly limit revenue when labor is insufficient, positioning automation as a present-day operational necessity rather than a future concept. Through its AI robotics strategy and TechForce Robotics subsidiary, Nightfood is presented as an infrastructure-focused solution provider designed to operate in high-volume settings, increase throughput and convert peak-demand congestion into measurable revenue rather than lost opportunity.

Rail Vision (NASDAQ: RVSN) announced that it has advanced to the next phase of its collaboration with Israel Railways, moving forward with a one-month evaluation pilot of its ShuntingYard system following a successful initial capability demonstration. The advancement builds on Israel Railways prior purchase and installation of Rail Vision MainLine systems and will evaluate ShuntingYard performance under local operating conditions to gather detailed operational feedback from the cargo team. Designed for stop-and-go rail yard environments, the ShuntingYard product combines electro-optical sensors and real-time AI to provide continuous situational awareness in low-light and adverse weather conditions. Upon successful completion of the pilot, Rail Vision and Israel Railways plan to explore deployment options aimed at improving safety, operational efficiency, and maintenance cost savings.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Gold recorded a powerful start to the year, climbing by over 13% an ounce last month. This makes it its strongest monthly performance since the late 90s. The precious metal’s rally was driven by a mix of geopolitical uncertainty and shifting macroeconomic expectations.

Fo llowing mounting evidence of dangerous failures, China has resolved to ban hidden EV door handles . China becomes the first country in the world to outlaw the contentious styling elements that Tesla, owned by multi-billionaire Elon Musk, brought to mainstream adoption.

A planned preclinical study testing a light-activated therapy that helps to kill residual brain cancer cells after a patient has undergone surgery to remove a tumor has elicited excitement as it could provide a way forward in eliminating microscopic cancer tissue that surgeons are unable to see while surgically removing a cancerous tumor from the brain.

On Wednesday, the UN Secretary General Antonio Guterres unveiled a list of nominees from which the General Assembly will select individuals who will constitute a scientific panel mandated to assess and make recommendations on how artificial intelligence can transform lives across the world.

America’s fledgling green energy industry is gaining traction despite President Donald Trump’s clear hostility to renewables, driven by economics that have made solar and wind the cheapest electricity options. Utility-scale solar delivers power at four to eight cents per kilowatt-hour without federal subsidies and battery-enhanced systems operate at five to 13 cents. Natural gas runs 13.8 to 26 cents per kilowatt-hour according to Lazard’s 2025 analysis, with coal commanding steeper prices.

A White House effort to resolve a prolonged dispute between major crypto firms and banks ended without a breakthrough, highlighting divisions that continue to stall major legislation aimed at regulating digital assets.

Audi is preparing to take a big step in its electric vehicle journey by planning to unveil a new entry-level EV model. This move shows that the luxury carmaker is serious about making electric cars more accessible to a wider group of buyers, not just those at the very top of the market. As electric vehicles become more popular around the world, Audi does not want to be left behind in the growing demand for affordable luxury EVs.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

This article has been disseminated on behalf of Powermax Minerals Inc. and may include paid advertising.

A pilot study conducted in Minnesota is pointing to a possible new way for scientists to study medical marijuana without becoming entangled in federal regulatory hurdles that have long limited clinical research in this area.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

A2Z Cust2Mate Solutions (NASDAQ: AZ) was featured in a recent article that discussed its work to restore visibility into shopper behavior with smart carts. The publication reads, “A2Z Cust2Mate CMO Yaniv Zukerman explains that while retailers have become highly proficient at tracking transactions, pricing and inventory, they have steadily lost visibility into how shoppers actually behave inside the store . Most existing systems capture only end results, such as what was purchased and when, leaving the entire in-aisle journey largely invisible. This disconnect, he argues, creates a growing gap between how well retailers believe they understand their customers and how little they truly know about the decisions, hesitations and trade-offs that shape each shopping trip.”

Xeriant (OTCQB: XERI) is a technology development company focused on discovering, developing and commercializing disruptive innovations, with advanced materials representing a core area of emphasis. “The most visible example of Xeriant’s advanced materials work is NEXBOARD(TM), a patent-pending composite panel that integrates recycled plastics, cellulose fibers and nanotechnology-enabled fire-retardant systems… Beyond individual milestones, Xeriant’s work in advanced materials reflects a broader strategy of applying nanotechnology to solve real-world performance challenges,” reads a recent article. “Across construction, infrastructure, industrial manufacturing and public safety, demand is rising for materials that can deliver greater durability, fire resistance and sustainability without sacrificing performance or cost efficiency. Governments, insurers and commercial buyers are increasingly focused on reducing fire risk, improving resilience and lowering environmental impact, driving interest in alternatives to traditional materials that are often resource-intensive or vulnerable under extreme conditions. Xeriant has been advancing a portfolio of advanced materials technologies that leverage nanotechnology to address these growing global needs.”

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, is extending its electronic monitoring footprint in the U.S. Midwest, announcing a third county-level deployment in Wisconsin just months after entering the state. The latest project, disclosed on February 2, represents the company’s fifth new EM launch since the beginning of the year and underscores how SuperCom is scaling through established regional partnerships once an initial foothold is secured ( https://ibn.fm/kjLnr ).

Knightscope (NASDAQ: KSCP) announced it has retained Lake Street Capital Markets as its exclusive buy-side financial advisor to support the company’s growth strategy through selective acquisitions of complementary businesses, technologies and capabilities. The engagement aligns with Knightscope’s long-term plan to build an integrated managed security services platform combining autonomous machines, advanced software and human operations, as the company evaluates potential transactions to strengthen its technology stack and service offerings, with no specific acquisition timetable or commitments currently in place.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Rail Vision (NASDAQ: RVSN) announced that its majority owned subsidiary, Quantum Transportation Ltd., has successfully developed and validated a first-generation transformer-based neural decoder designed to advance scalable quantum error correction. The company said the code-agnostic decoder demonstrated superior accuracy and efficiency in simulations across multiple quantum error correction codes and realistic noise environments, outperforming established classical decoding methods such as minimum-weight perfect matching and union-find, while supporting Rail Vision’s longer-term strategy of leveraging quantum-AI innovations alongside its core railway safety and vision technologies.

SEGG Media (NASDAQ: SEGG, LTRYW) announced the appointment of Simon Lewis as Executive Vice President of Entertainment for SEGG Media and Chief Executive Officer of DotCom Ventures Inc., the subsidiary operating Concerts.com and TicketStub.com, as the company advances both platforms from development into commercial execution. Lewis, a former advisor to the company and a veteran of the global live entertainment industry with prior tenure as President of Live Nation Europe, will oversee SEGG Media’s live entertainment strategy and lead the build-out and launch of Concerts.com and TicketStub.com, supporting the Board’s focus on accelerating commercialization and disciplined platform launches across the company’s entertainment portfolio.

Nightfood Holdings (OTCQB: NGTF) announced its placement in an editorial published by AINewsWire, a brand within the InvestorBrandNetwork platform, examining how artificial intelligence and robotics are addressing revenue constraints caused by labor shortages in high-traffic hospitality venues. The article highlights Nightfood’s strategy of developing a hospitality-focused AI robotics platform through its TechForce Robotics subsidiary to help stadiums, airports, convention centers and live-event locations improve service speed, increase throughput, and recover lost revenue during peak demand periods without adding headcount.

Massimo Group (NASDAQ: MAMO) announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show in Orlando, Florida, as part of its strategy to expand fleet sales, strengthen its dealer network, and introduce its premium MVR HVAC Pro Series to commercial and institutional customers. At the event, the company will present its second-generation MVR HVAC Pro Series, including Golf and Cargo Max configurations, following strong momentum from earlier 2026 industry shows that generated more than 100 dealer leads, alongside reported January dealer-channel sales growth of more than 150% year over year and early international distribution interest for the HVAC Pro platform.